The Global Needle-Free Drug Injection Systems Market size is expected to grow from $1.5 Billion in 2017 to $2.6 Billion by 2028, at a CAGR of 9%. The rise in awareness about better healthcare and hygiene practices has led to an increase in demand for needle-free injectors. The rising prevalence of chronic diseases such as diabetes is also driving the growth of this market. In addition, technological advancements and new product launches are expected to propel the growth of this market over the next few years.
Needle-Free Drug Injection Systems are devices used for administering medications through the skin without using a needle. They are noninvasive devices that have been designed with the intention of reducing needle-related injuries and infection risks.
On the basis of Types, the market is segmented into Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free injectors, and Vibration-Based Needle-Free Injectors.
Jet-Based Needle-Free Injectors are the smallest type of needle-free injections. These devices use gas to propel drugs through an opening at high speed, quickly penetrating the skin without creating any pain or discomfort for patients. They can be used in either self-care (homecare) settings or clinical settings where they may replace syringe needles as the administration route for interventional procedures like vaccines and insulin.
Spring-based needle-free injectors are devices that use compressed air to propel a drug through the skin into the body. The technology is similar to an aerosol spray can and in the application, it works like a syringe with no need for needles or injections of any kind. Spring-based needle-free injectors have largely replaced hypodermic needles because they do not carry disease risks from previous patients' blood and also reduce the risk of accidental injuries such as cuts caused by sharps disposal mishaps.
Laser-Powered Needle-Free Injectors are a needle-free injection system that is powered by laser. The device projects the drug with therapeutic effect through the skin while preventing any piercing of the tissue or vessel wall and eliminating blood contact, which poses a risk for infection transmission in healthcare facilities.
Vibration-based needle-free injectors are devices that use a spring mechanism, which is activated by an electric motor. The device can be used for intradermal or subcutaneous injections. They come in two types: the rotational vibrator and the reciprocating vibrator. Vibrators have been shown to reduce pain substantially more than traditional needles.
It may also provide benefits such as increased patient comfort, reduced anxiety, and improved injection technique because it takes less effort to hold down on the skin with this type of delivery system so there's less chance of poking too deeply into muscle tissue or accidentally hitting nerves underneath without moving away from the target site before injecting medication.
On the basis of Application, the market is segmented into Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology companies, Other End Users.
The hospitals and clinics segment dominates the Global Needle-Free Drug Injection Systems market. This is primarily due to various factors, such as increasing rates of the population with chronic diseases like diabetes mellitus type-II or hepatitis C virus (HCV) infection which calls for an increased number of needle-free injections in these settings.
The home care settings are also expected to witness positive growth during the forecast period owing to the rising cases of infectious diseases through needles which necessitates safe injection practices by caregivers at homes.
The research laboratories segment includes a variety of end-users who require needlestick injuries prevention on an experimental basis without posing any health hazard whatsoever, including biotechnology companies, pharmaceutical companies, etc., this will have a positive impact on the global needle free drug injection systems market for 2021-2028.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Europe accounted for a major share in terms of revenue and is likely to maintain its dominance during the forecast period, owing to the stringent regulatory measures set by WHO on needle safety practices which will have a positive impact on this segment.
Asia Pacific & Middle East Africa (APAC&MEA): Increasing awareness about risks involved with injections that necessitate needlestick injuries prevention has fueled growth in this region, thereby increasing demand for safe needle alternatives among patients and caregivers alike; thus leading towards pivotal infrastructure development as well as technological advancements being made by key players operating here.
Needle-Free Drug Injection Systems Market growth can be attributed to factors such as the increasing global prevalence of chronic diseases, high demand for cost-effective and time-saving drug delivery methods. Increasing healthcare expenditure by governments is also driving the market. However, a lack of awareness about needle-free injectors among patients living in remote areas is considered a major challenge faced by this industry.
Up Market Research published a new report titled “Needle Free Drug Injection Systems Market research report which is segmented by Types (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), By Applications (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology companies, Other End Users), By Players/Companies Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Valeritas, Inc. (US), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France)”.
|Report Attributes||Report Details|
|Report Title||Needle Free Drug Injection Systems Market Research Report|
|By Type||Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors|
|By Application||Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology companies, Other End Users|
|By Companies||Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Valeritas, Inc. (US), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France)|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||200|
|Number of Tables & Figures||140|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors and By Application Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology companies, Other End Users.
Some of the companies that are profiled in this report are:
Needle Free Drug Injection Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Needle Free Drug Injection Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Needle Free Drug Injection Systems Market Report:
Some other reports from this category!